Previous in vitro and in vivo results showed that the reduction of CXCL8 and CCL2 secretion inhibits some of the pro-tumorigenic effects mediated by both these chemokines in thyroid cancer (32). This evidence concerns the gene CCL2 and thyroid cancer.